Early research (Phase 1)Study completedNCT00390338What this trial is testingVaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) Pawel Kalinski 22
Testing effectiveness (Phase 2)Ended earlyNCT05234437What this trial is testingA Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c MelanomaWho this might be right forMelanoma QBiotics Group Limited 1
Large-scale testing (Phase 3)Study completedNCT02714218What this trial is testingTwo Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 387
Large-scale testing (Phase 3)Ended earlyNCT02288897What this trial is testingPV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous MelanomaWho this might be right forCutaneous Melanoma Provectus Biopharmaceuticals, Inc. 20
Early research (Phase 1)Study completedNCT01496807What this trial is testingYervoy With Sylatron Unresectable Stage 3 or 4 MelanomaWho this might be right forMelanoma H. Lee Moffitt Cancer Center and Research Institute 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT02858921What this trial is testingNeoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III MelanomaWho this might be right forMelanoma Melanoma Institute Australia 60
Not applicableLooking for participantsNCT06754904What this trial is testingOmitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph NodeWho this might be right forMelanoma, Skin D.J. (Dirk) Grünhagen 213
Testing effectiveness (Phase 2)WithdrawnNCT03220009What this trial is testingNivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWho this might be right forCervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01835145What this trial is testingCabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by SurgeryWho this might be right forRecurrent Uveal MelanomaStage III Uveal Melanoma AJCC v7Stage IIIA Uveal Melanoma AJCC v7+3 more National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT02231775What this trial is testingDabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 MutationWho this might be right forStage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7 M.D. Anderson Cancer Center 58
Not applicableStudy completedNCT02857374What this trial is testingIntravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node BiopsyWho this might be right forStage IB Skin MelanomaStage IIA Skin MelanomaStage IIB Skin Melanoma+4 more Roswell Park Cancer Institute 20
Early research (Phase 1)Looking for participantsNCT03819296What this trial is testingRole of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerWho this might be right forClinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+41 more M.D. Anderson Cancer Center 800
Not applicableWithdrawnNCT02507076What this trial is testingIsolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or SarcomaWho this might be right forBasal Cell Carcinoma of the SkinEccrine Carcinoma of the SkinRecurrent Adult Soft Tissue Sarcoma+8 more Albert Einstein College of Medicine
Testing effectiveness (Phase 2)Study completedNCT04330430What this trial is testingNeo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (stage IIIB/C/D-IV M1a) Melanoma with Injectable DiseaseWho this might be right forMelanoma Stage IIIMelanoma Stage IV The Netherlands Cancer Institute 24
Early research (Phase 1)Ended earlyNCT02097225What this trial is testingOnalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forBRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more National Cancer Institute (NCI) 22
Not applicableStudy completedNCT03707574What this trial is testingGenetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyWho this might be right forAdvanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Ended earlyNCT02587650What this trial is testingCapmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV MelanomaWho this might be right forALK Fusion Protein ExpressionBRAF wt AlleleInvasive Skin Melanoma+12 more University of California, San Francisco 1
Testing effectiveness (Phase 2)Study completedNCT02970981What this trial is testingStudy of Combination of Ipilimumab and Nivolumab in Patients With MelanomaWho this might be right forMelanoma NYU Langone Health 18
Large-scale testing (Phase 3)Study completedNCT00769704What this trial is testingEfficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in MelanomaWho this might be right forMelanoma BioVex Limited 437
Testing effectiveness (Phase 2)Ended earlyNCT02359851What this trial is testingPembrolizumab in Treating Patients With Advanced Uveal MelanomaWho this might be right forStage IIIA Uveal MelanomaStage IIIB Uveal MelanomaStage IIIC Uveal Melanoma+1 more Vanderbilt-Ingram Cancer Center 5